Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Liotta, L.A. TI - Cancer cell invasion and metastasis JO - Sci. Am. PY - 1992/// VL - 266 SP - 34 EP - 41 ER - TY - JOUR AU - O'Reilly, M.S. TI - Angiostatin: a novel angiogenesis inhibitor that mediates the supression of metastases by a lewis lung carcinoma JO - Cell PY - 1994/// VL - 79 SP - 315 EP - 328 ER - TY - JOUR AU - O'Reilly, M.S. TI - Endostatin: an endogenous inhibitor of angiogenesis and tumor growth JO - Cell PY - 1997/// VL - 88 SP - 277 EP - 285 ER - TY - JOUR AU - Millauer, B. AU - Shawver, L.K. AU - Plate, K.H. AU - Risau, W. AU - Ullrich, A. TI - Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant JO - Nature PY - 1994/// VL - 367 SP - 576 EP - 579 ER - TY - JOUR AU - Millauer, B. TI - Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo JO - Cancer Res. PY - 1996/// VL - 56 SP - 1615 EP - 1620 ER - TY - JOUR AU - Kim, K.J. TI - Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo JO - Nature PY - 1993/// VL - 362 SP - 841 EP - 844 ER - TY - JOUR AU - Saleh, M. AU - Stacker, S.A. AU - Wilks, A.F. TI - Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence JO - Cancer Res. PY - 1996/// VL - 56 SP - 393 EP - 401 ER - TY - JOUR AU - Achen, M.G. TI - Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4) JO - Proc. Natl. Acad. Sci. USA PY - 1998/// VL - 95 SP - 548 EP - 553 ER - TY - JOUR AU - Orlandini, M. AU - Marconcini, L. AU - Ferruzzi, R. AU - Oliviero, S. TI - Identification of a C-Fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family JO - Proc. Natl. Acad. Sci. USA PY - 1996/// VL - 93 SP - 11675 EP - 11680 ER - TY - JOUR AU - Kaipainen, A. TI - Expression of the Fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development JO - Proc. Natl. Acad. Sci. USA PY - 1995/// VL - 92 SP - 3566 EP - 3570 ER - TY - JOUR AU - Taipale, J. TI - Vascular endothelial growth factor receptor-3 JO - Curr. Top. Microbiol. Immunol. PY - 1999/// VL - 237 SP - 85 EP - 96 ER - TY - JOUR AU - Dukes, C.E. TI - The classification of cancer of the rectum JO - J. Pathol. PY - 1932/// VL - 35 SP - 323 EP - 332 ER - TY - JOUR AU - Fisher, B. TI - Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update JO - Cancer PY - 1983/// VL - 52 SP - 1551 EP - 1557 ER - TY - JOUR AU - Stacker, S.A. AU - Achen, M.G. TI - The vascular endothelial growth factor family: signaling for vascular development JO - Growth Factors PY - 1999/// VL - 17 SP - 1 EP - 11 ER - TY - JOUR AU - Stacker, S.A. TI - Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers JO - J. Biol. Chem. PY - 1999/// VL - 274 SP - 32127 EP - 32136 ER - TY - JOUR AU - Achen, M.G. TI - Monoclonal antibodies to vascular endothelial growth factor-D block interactions with both VEGF receptor-2 and VEGF receptor-3 JO - Eur.J.Biochem. PY - 2000/// VL - 267 SP - 2505 EP - 2515 ER - TY - JOUR AU - Valtola, R. TI - VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer JO - Am. J. Pathol. PY - 1999/// VL - 154 SP - 1381 EP - 1390 ER - TY - JOUR AU - Banerji, S. TI - LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan JO - J. Cell Biol. PY - 1999/// VL - 144 SP - 789 EP - 801 ER - TY - JOUR AU - de Waal, R.M.W. TI - Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination JO - Am. J. Pathol. PY - 1997/// VL - 150 SP - 1951 EP - 1957 ER - TY - JOUR AU - Prewett, M. TI - Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors JO - Cancer Res. PY - 1999/// VL - 59 SP - 5209 EP - 5218 ER - TY - JOUR AU - Whiteside, T.L. AU - Herberman, R.B. TI - The role of natural killer cells in immune surveillance of cancer JO - Curr. Opin. Immunol. PY - 1995/// VL - 7 SP - 704 EP - 710 ER - TY - JOUR AU - Vujanovic, N.L. AU - Basse, P. AU - Herberman, R.B. AU - Whiteside, T.L. TI - Antitumor functions of natural killer cells and control of metastases JO - Methods PY - 1996/// VL - 9 SP - 394 EP - 408 ER - TY - JOUR AU - Babu, S. AU - Porte, P. AU - Klei, T.R. AU - Shultz, L.D. AU - Rajan, T.V. TI - Host NK cells are required for the growth of the human filarial parasite Brugia malayi in mice JO - J. Immunol. PY - 1998/// VL - 161 SP - 1428 EP - 1432 ER - TY - JOUR AU - Ansink, A.C. TI - Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a Patent Blue V injection: a multicenter study JO - Cancer PY - 1999/// VL - 86 SP - 652 EP - 656 ER - TY - JOUR AU - Folkman, J. TI - Anti-angiogenesis: new concepts of therapy of solid tumors JO - Ann. Surg. PY - 1972/// VL - 175 SP - 409 EP - 416 ER - TY - JOUR AU - Folkman, J. AU - Klagsburn, M. TI - Angiogenic factors JO - Science PY - 1987/// VL - 235 SP - 442 EP - 447 ER - TY - JOUR AU - Folkman, J. TI - What is the evidence that tumors are angiogenesis dependent? JO - J. Natl. Cancer Inst. PY - 1990/// VL - 82 SP - 4 EP - 6 ER - TY - JOUR AU - Folkman, J. AU - D'Amore, P.A. TI - Blood vessel formation:what is its molecular basis? JO - Cell PY - 1996/// VL - 87 SP - 1153 EP - 1155 ER - TY - JOUR AU - Wood, J.M. TI - PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration JO - Cancer Res. PY - 2000/// VL - 60 SP - 2178 EP - 2189 ER - TY - JOUR AU - Drevs, J. TI - Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model JO - Cancer Res. PY - 2000/// VL - 60 SP - 4819 EP - 4824 ER - TY - JOUR AU - Lymboussaki, A. AU - Achen, M.G. AU - Stacker, S.A. AU - Alitalo, K. TI - Growth factors regulating lymphatic vessels JO - Curr. Top. Microbiol. Immunol. PY - 2000/// VL - 251 SP - 75 EP - 82 ER - TY - JOUR AU - Leu, A.J. AU - Berk, D.A. AU - Lymboussaki, A. AU - Alitalo, K. AU - Jain, R.K. TI - Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation JO - Cancer Res. PY - 2000/// VL - 60 SP - 4324 EP - 4327 ER - TY - JOUR AU - Lymboussaki, A. TI - Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors JO - Am. J. Pathol. PY - 1998/// VL - 153 SP - 395 EP - 403 ER - TY - JOUR AU - Joukov, V. TI - A novel vascular endothelial growth factor, VEGF-C, Is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases JO - EMBO J. PY - 1996/// VL - 15 SP - 290 EP - 298 ER - TY - JOUR AU - Kubo, H. TI - Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis JO - Blood PY - 2000/// VL - 96 SP - 546 EP - 553 ER - TY - JOUR AU - Salven, P. TI - Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors JO - Am. J. Pathol. PY - 1998/// VL - 153 SP - 103 EP - 108 ER - TY - JOUR AU - Achen, M.G. TI - Localisation of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis JO - J. Pathol. PY - /// SP - EP - ER - TY - JOUR AU - Plate, K.H. AU - Breier, G. AU - Millauer, B. AU - Ullrich, A. AU - Risau, W. TI - Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis JO - Cancer Res. PY - 1993/// VL - 53 SP - 5822 EP - 5827 ER - TY - JOUR AU - Niki, T. TI - Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma JO - Clin. Cancer Res. PY - 2000/// VL - 6 SP - 2431 EP - 2439 ER - TY - JOUR AU - Mandriota, S.J. TI - Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis JO - EMBOJ. PY - 2001/// SP - EP - ER - TY - JOUR AU - Layton, J.E. AU - Iaria, J. AU - Nicholson, S.E. TI - Neutralising antibodies to the granulocyte colony-stimulating factor receptor recognise both the immunoglobulin-like domain and the cytokine receptor homologous domain JO - Growth Factors. PY - 1997/// VL - 14 SP - 117 EP - 130 ER -